论文信息 - Abstract 4956: CD34bright/CD133negcandidate circulating endothelial progenitor cells (ccEPCs) are a potential biomarker during treatment with sunitinib or bevacizumab - 字舞流文

Abstract 4956: CD34bright/CD133negcandidate circulating endothelial progenitor cells (ccEPCs) are a potential biomarker during treatment with sunitinib or bevacizumab

E. Smit | G. Schuurhuis | A. Veldt | H. Broxterman | E. Boven | V. Hinsbergh | A. Eertwegh | K. Hoekman | H. Cruijsen | L. Vroling | R. R. Haas